Yikes! It's a tricky market out there. And you had better be either very nimble or very patient. Count on one thing, though: This volatility will pass. It always passes. And then we'll either trend, or the market will be so darn dull, I'll be pulling my hair out.
And since I haven't looked at the market -- or is it markets, these days? -- in a while, I'll supplement today's column and Sunday's column with a look at the
S&P 500 Spiders
Nasdaq 100 tracking stock
. Today, the first two.
OK, don't forget, our address is
firstname.lastname@example.org. I'm here solely to answer your questions!
And now a few readers' letters that have drifted in since I got back from vacation.
Broken or Shaken?
Gary: I'm having trouble telling if Internet Capital Group (ICGE) has broken support or is just experiencing a normal shake-out. Jim Falletta
Should Biologist Bet His Biopharm?
Gary: My arcade ride has been Geron (GERN) - Get Report. I bought shares of this stock at a very low price of 9 to 11 last year. The company has tremendous long-term potential. I'm a science guy and understand these things. Now, as a biologist, I don't have a lot of money. I picked up as much as I could at 9 to 11, then it started to move up. My problem is that it burped up on March 10, opened 7 lower on March 13 and crashed another 12 on March 14. I'm still long on this stock and view it as a legacy. Is there something in the charts that indicated this, or is it just one of those things? I'm looking for some direction here. George Pringle
Price Check on priceline.com
Gary: I'd love to see a new chart on priceline.com (PCLN) . I sold at 85 with a very nice profit. Now the question: Should I buy again and wait for another rise? What does the chart say? Joanne Matejov
Gary: I picked up TriQuint Semiconductor (TQNT) at 88 yesterday. Could you take a look at the chart? Collin Morrow
Gary B. Smith is a freelance writer who trades for his own account from his Maryland home using technical analysis. At time of publication, he held no positions in any securities mentioned in this column, although holdings can change at any time. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Smith writes five technical analysis columns for TheStreet.com each week, including Technician's Take, Charted Territory and TSC Technical Forum. While he cannot provide investment advice or recommendations, he welcomes your feedback at